A quiet month, but deal count held up

Indian tech and startup funding fell to $693.8 million across 101 rounds in October 2026, according to data from Tracxn reported by ETtech on 30 October. That is down 22.8 per cent from September and 50.5 per cent lower than the same month last year — a sobering headline for startup funding in India as the month closed.

Even Healthcare led deal activity during the month with $50 million, followed by Different at $48 million, Boldfit at $41.5 million, Baba Care at $40 million and GreenCell Mobility at $34.5 million. Early-stage deals accounted for 61.9 per cent of the capital raised during October, while late-stage transactions made up 19.4 per cent and seed-stage companies the remaining 18.7 per cent — early-stage money, in other words, carried the month.

The final week of October was softer still: funding fell to $111.1 million across 26 rounds, down 54.8 per cent from the previous week and 58.6 per cent lower than the same period last year. Early-stage deals accounted for 75.4 per cent of that week's funding, with seed-stage rounds making up the rest. Within the week, Cent led with $15 million, followed by Clinics On Cloud at $14.3 million, Simplismart at $14 million, Troovy at $10.5 million and Matiks at $10 million.

On the investor front, Blume Ventures, AJVC and 3one4 Capital were among the most active investors during October. Blume backed Lumio, Hunar.AI, Cent, Rotoris, QwikBuild and Harajuku; AJVC participated in rounds of Scooter, Kinetic Age, Island Beauty, Unveilr and Wudhomes; while 3one4 Capital invested in Sunfox, Lumio, Ace Blend, dubdub and Scimplify. Activity, in short, concentrated in a handful of familiar early-stage names even as totals fell.

The month's shape matters more than any single round: fewer mega-rounds, a bigger early-stage share, and a final week dominated by seed and early cheques. That is a market rewarding traction and discipline over blitz-scaling narratives.

Why it matters for founders

A down month is not a closed market: 101 rounds still closed in October, and early-stage deals took nearly two-thirds of the money. Founders raising now should pitch capital efficiency and a clear path to the next milestone — the investors writing the most cheques, like Blume, AJVC and 3one4, are visibly backing teams that can show both.